Vibramycin
Rocky Mountain Spotted Fever, Acinetobacter Infections, Ureaplasma Infections + 61 more
Treatment
93 FDA approvals
20 Active Studies for Vibramycin
Treatment for
Rocky Mountain Spotted Fever
What is Vibramycin
Doxycycline
The Generic name of this drug
Treatment Summary
Doxycycline is a synthetic antibiotic used to treat a variety of bacterial infections. It is a second-generation tetracycline, meaning it is less toxic than other related antibiotics. Doxycycline can be used to treat various bacterial infections depending on the results of antibiotic susceptibility testing.
Vibramycin Hyclate
is the brand name
Vibramycin Overview & Background
Brand Name
Generic Name
First FDA Approval
How many FDA approvals?
Vibramycin Hyclate
Doxycycline
1967
728
Approved as Treatment by the FDA
Doxycycline, otherwise known as Vibramycin Hyclate, is approved by the FDA for 93 uses such as Severe Acne and Streptococcus Pneumoniae Infections .
Severe Acne
Streptococcus Pneumoniae Infections
Intestinal Amebiasis
Chlamydia Infections
Primary Syphilis
Anal chlamydia infection
Upper Respiratory Tract Infection
Clostridium difficile Infection
Genus Chlamydia
Communicable Diseases
Actinomycosis
Secondary Syphilis
Rickettsialpox
Klebsiella Infections
Cholera (Disorder)
Campylobacter Infections
Mycoplasma Pneumoniae
Inclusion conjunctivitis
Necrotizing ulcerative gingivostomatitis
Chlamydia Infections
Urethritis
Ureaplasma urethritis
Chlamydial Urethritis
Listeria infection
Urinary Tract Infections
Bacteriological Techniques
Staphylococcus (S.) Aureus Infection
Relapsing fever caused by Borrelia recurrentis
Campylobacter Infection
Tick-borne fever
Plasmodium Infections
Skin Infections
Chlamydia trachomatis
Typhus, Endemic Flea-Borne
Communicable Diseases
Chlamydial cervicitis
Haemophilus Influenzae Infections
Calymmatobacterium granulomatis
Lymphogranuloma Venereum
Dysentery, Bacillary
Fever
Gonorrhea
Bartonella Infections
Acne Vulgaris
Q Fever
Acinetobacter Infections
Ureaplasma Infections
Communicable Diseases
Uterine Cervicitis
Tularemia
Typhus infections
Epididymo-orchitis gonococcal
Trachoma
Neisseria Gonorrhoeae Infection
Rocky Mountain Spotted Fever
Bartonella bacilliformis infections
Malaria
Bacterial Infection caused by Enterobacter aerogenes
Relapsing Fever
Yaws
Chancroid
Amebic colitis
Brucellosis
Used to treat Brucellosis in combination with Streptomycin
Recurrent Upper and Lower Respiratory Tract Infections (RTIs)
Plague
Chlamydia trachomatis
Cat-Scratch Disease
Shigella Infection
inhaled anthrax caused by Bacillus anthracis
Pneumococcal Infections
Clostridium Infections
Common Cold
Brucellosis
Used to treat Brucellosis in combination with Streptomycin
Trachoma
Plague
Urethritis
Acinetobacter Infections
Yersinia pestis
Psittacosis
Chlamydia psitacci infection
Ureaplasma Infections
Infection Due to Escherichia Coli
Trachoma inclusion conjunctivitis
Listeriosis
Yaws
Relapsing Fever
Vibrio Cholerae Infection
Disease
Haemophilus ducreyi infection
Tularemia
prophylaxis of Malaria
Respiratory Tract Infections
Granuloma Inguinale
Effectiveness
How Vibramycin Affects Patients
Doxycycline is a type of medication called a tetracycline, which is designed to stop the growth of bacteria. It works by blocking the protein production of the bacteria, preventing it from continuing to spread. Doxycycline is also lipophilic and can penetrate the cell walls of bacteria. This makes it effective in treating a wide range of bacterial infections. Additionally, it has been shown to have anti-parasitic and anti-inflammatory effects, and has been used to treat certain skin conditions such as bullous dermatoses and rosacea.
How Vibramycin works in the body
Doxycycline stops bacteria from being able to make proteins they need to survive. It works by preventing an amino acid-carrying molecule from binding to the ribosome, a component of bacterial cells. This blocks the production of essential proteins and eventually kills the bacteria. Doxycycline also reduces inflammation by blocking the movement of white blood cells and stopping an enzyme that produces a chemical messenger that causes inflammation.
When to interrupt dosage
The suggested dosage of Vibramycin is reliant upon the determined condition, including Urethritis, Chlamydia trachomatis and Respiratory Tract Infections. The measure of dosage varies, as per the technique of delivery (e.g. Capsule or Syrup - Oral) listed in the table beneath.
Condition
Dosage
Administration
Urinary Tract Infections
10.0 mg/mL, , 75.0 mg, 100.0 mg, 150.0 mg, 50.0 mg, 200.0 mg, 20.0 mg, 1.0 mg/mg, 40.0 mg, 5.0 mg/mg, 7.5 mg/mg, 25.0 mg/mL, 50.0 mg/mL, 120.0 mg, 60.0 mg, 0.1 mg/mg, 5.0 mg/mL, 8.8 %, 20.0 mg/mL, 0.75 mg/mg, 0.5 mg/mg, 80.0 mg
, Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Oral, Tablet, delayed release, Tablet, delayed release - Oral, Capsule, Capsule - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Tablet, coated, Tablet, coated - Oral, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Capsule, extended release - Oral, Capsule, extended release, Powder - Intravenous, Powder, Powder, for suspension, Syrup, Syrup - Oral, Powder, for suspension - Oral, Kit - Oral, For suspension, For suspension - Oral, Capsule, Delayed Release - Oral, Capsule, Delayed Release, Kit, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Oral; Topical, Capsule - Oral; Topical, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Gel - Oral, Suspension - Oral
Primary Syphilis
10.0 mg/mL, , 75.0 mg, 100.0 mg, 150.0 mg, 50.0 mg, 200.0 mg, 20.0 mg, 1.0 mg/mg, 40.0 mg, 5.0 mg/mg, 7.5 mg/mg, 25.0 mg/mL, 50.0 mg/mL, 120.0 mg, 60.0 mg, 0.1 mg/mg, 5.0 mg/mL, 8.8 %, 20.0 mg/mL, 0.75 mg/mg, 0.5 mg/mg, 80.0 mg
, Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Oral, Tablet, delayed release, Tablet, delayed release - Oral, Capsule, Capsule - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Tablet, coated, Tablet, coated - Oral, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Capsule, extended release - Oral, Capsule, extended release, Powder - Intravenous, Powder, Powder, for suspension, Syrup, Syrup - Oral, Powder, for suspension - Oral, Kit - Oral, For suspension, For suspension - Oral, Capsule, Delayed Release - Oral, Capsule, Delayed Release, Kit, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Oral; Topical, Capsule - Oral; Topical, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Gel - Oral, Suspension - Oral
inhaled anthrax caused by Bacillus anthracis
10.0 mg/mL, , 75.0 mg, 100.0 mg, 150.0 mg, 50.0 mg, 200.0 mg, 20.0 mg, 1.0 mg/mg, 40.0 mg, 5.0 mg/mg, 7.5 mg/mg, 25.0 mg/mL, 50.0 mg/mL, 120.0 mg, 60.0 mg, 0.1 mg/mg, 5.0 mg/mL, 8.8 %, 20.0 mg/mL, 0.75 mg/mg, 0.5 mg/mg, 80.0 mg
, Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Oral, Tablet, delayed release, Tablet, delayed release - Oral, Capsule, Capsule - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Tablet, coated, Tablet, coated - Oral, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Capsule, extended release - Oral, Capsule, extended release, Powder - Intravenous, Powder, Powder, for suspension, Syrup, Syrup - Oral, Powder, for suspension - Oral, Kit - Oral, For suspension, For suspension - Oral, Capsule, Delayed Release - Oral, Capsule, Delayed Release, Kit, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Oral; Topical, Capsule - Oral; Topical, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Gel - Oral, Suspension - Oral
Psittacosis
10.0 mg/mL, , 75.0 mg, 100.0 mg, 150.0 mg, 50.0 mg, 200.0 mg, 20.0 mg, 1.0 mg/mg, 40.0 mg, 5.0 mg/mg, 7.5 mg/mg, 25.0 mg/mL, 50.0 mg/mL, 120.0 mg, 60.0 mg, 0.1 mg/mg, 5.0 mg/mL, 8.8 %, 20.0 mg/mL, 0.75 mg/mg, 0.5 mg/mg, 80.0 mg
, Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Oral, Tablet, delayed release, Tablet, delayed release - Oral, Capsule, Capsule - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Tablet, coated, Tablet, coated - Oral, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Capsule, extended release - Oral, Capsule, extended release, Powder - Intravenous, Powder, Powder, for suspension, Syrup, Syrup - Oral, Powder, for suspension - Oral, Kit - Oral, For suspension, For suspension - Oral, Capsule, Delayed Release - Oral, Capsule, Delayed Release, Kit, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Oral; Topical, Capsule - Oral; Topical, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Gel - Oral, Suspension - Oral
Brucellosis
10.0 mg/mL, , 75.0 mg, 100.0 mg, 150.0 mg, 50.0 mg, 200.0 mg, 20.0 mg, 1.0 mg/mg, 40.0 mg, 5.0 mg/mg, 7.5 mg/mg, 25.0 mg/mL, 50.0 mg/mL, 120.0 mg, 60.0 mg, 0.1 mg/mg, 5.0 mg/mL, 8.8 %, 20.0 mg/mL, 0.75 mg/mg, 0.5 mg/mg, 80.0 mg
, Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Oral, Tablet, delayed release, Tablet, delayed release - Oral, Capsule, Capsule - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Tablet, coated, Tablet, coated - Oral, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Capsule, extended release - Oral, Capsule, extended release, Powder - Intravenous, Powder, Powder, for suspension, Syrup, Syrup - Oral, Powder, for suspension - Oral, Kit - Oral, For suspension, For suspension - Oral, Capsule, Delayed Release - Oral, Capsule, Delayed Release, Kit, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Oral; Topical, Capsule - Oral; Topical, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Gel - Oral, Suspension - Oral
Bacteriological Techniques
10.0 mg/mL, , 75.0 mg, 100.0 mg, 150.0 mg, 50.0 mg, 200.0 mg, 20.0 mg, 1.0 mg/mg, 40.0 mg, 5.0 mg/mg, 7.5 mg/mg, 25.0 mg/mL, 50.0 mg/mL, 120.0 mg, 60.0 mg, 0.1 mg/mg, 5.0 mg/mL, 8.8 %, 20.0 mg/mL, 0.75 mg/mg, 0.5 mg/mg, 80.0 mg
, Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Oral, Tablet, delayed release, Tablet, delayed release - Oral, Capsule, Capsule - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Tablet, coated, Tablet, coated - Oral, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Capsule, extended release - Oral, Capsule, extended release, Powder - Intravenous, Powder, Powder, for suspension, Syrup, Syrup - Oral, Powder, for suspension - Oral, Kit - Oral, For suspension, For suspension - Oral, Capsule, Delayed Release - Oral, Capsule, Delayed Release, Kit, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Oral; Topical, Capsule - Oral; Topical, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Gel - Oral, Suspension - Oral
Relapsing Fever
10.0 mg/mL, , 75.0 mg, 100.0 mg, 150.0 mg, 50.0 mg, 200.0 mg, 20.0 mg, 1.0 mg/mg, 40.0 mg, 5.0 mg/mg, 7.5 mg/mg, 25.0 mg/mL, 50.0 mg/mL, 120.0 mg, 60.0 mg, 0.1 mg/mg, 5.0 mg/mL, 8.8 %, 20.0 mg/mL, 0.75 mg/mg, 0.5 mg/mg, 80.0 mg
, Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Oral, Tablet, delayed release, Tablet, delayed release - Oral, Capsule, Capsule - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Tablet, coated, Tablet, coated - Oral, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Capsule, extended release - Oral, Capsule, extended release, Powder - Intravenous, Powder, Powder, for suspension, Syrup, Syrup - Oral, Powder, for suspension - Oral, Kit - Oral, For suspension, For suspension - Oral, Capsule, Delayed Release - Oral, Capsule, Delayed Release, Kit, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Oral; Topical, Capsule - Oral; Topical, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Gel - Oral, Suspension - Oral
Actinomycosis
10.0 mg/mL, , 75.0 mg, 100.0 mg, 150.0 mg, 50.0 mg, 200.0 mg, 20.0 mg, 1.0 mg/mg, 40.0 mg, 5.0 mg/mg, 7.5 mg/mg, 25.0 mg/mL, 50.0 mg/mL, 120.0 mg, 60.0 mg, 0.1 mg/mg, 5.0 mg/mL, 8.8 %, 20.0 mg/mL, 0.75 mg/mg, 0.5 mg/mg, 80.0 mg
, Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Oral, Tablet, delayed release, Tablet, delayed release - Oral, Capsule, Capsule - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Tablet, coated, Tablet, coated - Oral, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Capsule, extended release - Oral, Capsule, extended release, Powder - Intravenous, Powder, Powder, for suspension, Syrup, Syrup - Oral, Powder, for suspension - Oral, Kit - Oral, For suspension, For suspension - Oral, Capsule, Delayed Release - Oral, Capsule, Delayed Release, Kit, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Oral; Topical, Capsule - Oral; Topical, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Gel - Oral, Suspension - Oral
prophylaxis of Malaria
10.0 mg/mL, , 75.0 mg, 100.0 mg, 150.0 mg, 50.0 mg, 200.0 mg, 20.0 mg, 1.0 mg/mg, 40.0 mg, 5.0 mg/mg, 7.5 mg/mg, 25.0 mg/mL, 50.0 mg/mL, 120.0 mg, 60.0 mg, 0.1 mg/mg, 5.0 mg/mL, 8.8 %, 20.0 mg/mL, 0.75 mg/mg, 0.5 mg/mg, 80.0 mg
, Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Oral, Tablet, delayed release, Tablet, delayed release - Oral, Capsule, Capsule - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Tablet, coated, Tablet, coated - Oral, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Capsule, extended release - Oral, Capsule, extended release, Powder - Intravenous, Powder, Powder, for suspension, Syrup, Syrup - Oral, Powder, for suspension - Oral, Kit - Oral, For suspension, For suspension - Oral, Capsule, Delayed Release - Oral, Capsule, Delayed Release, Kit, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Oral; Topical, Capsule - Oral; Topical, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Gel - Oral, Suspension - Oral
Mycoplasma Pneumoniae
10.0 mg/mL, , 75.0 mg, 100.0 mg, 150.0 mg, 50.0 mg, 200.0 mg, 20.0 mg, 1.0 mg/mg, 40.0 mg, 5.0 mg/mg, 7.5 mg/mg, 25.0 mg/mL, 50.0 mg/mL, 120.0 mg, 60.0 mg, 0.1 mg/mg, 5.0 mg/mL, 8.8 %, 20.0 mg/mL, 0.75 mg/mg, 0.5 mg/mg, 80.0 mg
, Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Oral, Tablet, delayed release, Tablet, delayed release - Oral, Capsule, Capsule - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Tablet, coated, Tablet, coated - Oral, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Capsule, extended release - Oral, Capsule, extended release, Powder - Intravenous, Powder, Powder, for suspension, Syrup, Syrup - Oral, Powder, for suspension - Oral, Kit - Oral, For suspension, For suspension - Oral, Capsule, Delayed Release - Oral, Capsule, Delayed Release, Kit, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Oral; Topical, Capsule - Oral; Topical, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Gel - Oral, Suspension - Oral
Chlamydia Infections
10.0 mg/mL, , 75.0 mg, 100.0 mg, 150.0 mg, 50.0 mg, 200.0 mg, 20.0 mg, 1.0 mg/mg, 40.0 mg, 5.0 mg/mg, 7.5 mg/mg, 25.0 mg/mL, 50.0 mg/mL, 120.0 mg, 60.0 mg, 0.1 mg/mg, 5.0 mg/mL, 8.8 %, 20.0 mg/mL, 0.75 mg/mg, 0.5 mg/mg, 80.0 mg
, Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Oral, Tablet, delayed release, Tablet, delayed release - Oral, Capsule, Capsule - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Tablet, coated, Tablet, coated - Oral, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Capsule, extended release - Oral, Capsule, extended release, Powder - Intravenous, Powder, Powder, for suspension, Syrup, Syrup - Oral, Powder, for suspension - Oral, Kit - Oral, For suspension, For suspension - Oral, Capsule, Delayed Release - Oral, Capsule, Delayed Release, Kit, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Oral; Topical, Capsule - Oral; Topical, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Gel - Oral, Suspension - Oral
Ureaplasma Infections
10.0 mg/mL, , 75.0 mg, 100.0 mg, 150.0 mg, 50.0 mg, 200.0 mg, 20.0 mg, 1.0 mg/mg, 40.0 mg, 5.0 mg/mg, 7.5 mg/mg, 25.0 mg/mL, 50.0 mg/mL, 120.0 mg, 60.0 mg, 0.1 mg/mg, 5.0 mg/mL, 8.8 %, 20.0 mg/mL, 0.75 mg/mg, 0.5 mg/mg, 80.0 mg
, Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Oral, Tablet, delayed release, Tablet, delayed release - Oral, Capsule, Capsule - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Tablet, coated, Tablet, coated - Oral, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Capsule, extended release - Oral, Capsule, extended release, Powder - Intravenous, Powder, Powder, for suspension, Syrup, Syrup - Oral, Powder, for suspension - Oral, Kit - Oral, For suspension, For suspension - Oral, Capsule, Delayed Release - Oral, Capsule, Delayed Release, Kit, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Oral; Topical, Capsule - Oral; Topical, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Gel - Oral, Suspension - Oral
Q Fever
10.0 mg/mL, , 75.0 mg, 100.0 mg, 150.0 mg, 50.0 mg, 200.0 mg, 20.0 mg, 1.0 mg/mg, 40.0 mg, 5.0 mg/mg, 7.5 mg/mg, 25.0 mg/mL, 50.0 mg/mL, 120.0 mg, 60.0 mg, 0.1 mg/mg, 5.0 mg/mL, 8.8 %, 20.0 mg/mL, 0.75 mg/mg, 0.5 mg/mg, 80.0 mg
, Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Oral, Tablet, delayed release, Tablet, delayed release - Oral, Capsule, Capsule - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Tablet, coated, Tablet, coated - Oral, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Capsule, extended release - Oral, Capsule, extended release, Powder - Intravenous, Powder, Powder, for suspension, Syrup, Syrup - Oral, Powder, for suspension - Oral, Kit - Oral, For suspension, For suspension - Oral, Capsule, Delayed Release - Oral, Capsule, Delayed Release, Kit, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Oral; Topical, Capsule - Oral; Topical, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Gel - Oral, Suspension - Oral
Epididymo-orchitis gonococcal
10.0 mg/mL, , 75.0 mg, 100.0 mg, 150.0 mg, 50.0 mg, 200.0 mg, 20.0 mg, 1.0 mg/mg, 40.0 mg, 5.0 mg/mg, 7.5 mg/mg, 25.0 mg/mL, 50.0 mg/mL, 120.0 mg, 60.0 mg, 0.1 mg/mg, 5.0 mg/mL, 8.8 %, 20.0 mg/mL, 0.75 mg/mg, 0.5 mg/mg, 80.0 mg
, Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Oral, Tablet, delayed release, Tablet, delayed release - Oral, Capsule, Capsule - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Tablet, coated, Tablet, coated - Oral, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Capsule, extended release - Oral, Capsule, extended release, Powder - Intravenous, Powder, Powder, for suspension, Syrup, Syrup - Oral, Powder, for suspension - Oral, Kit - Oral, For suspension, For suspension - Oral, Capsule, Delayed Release - Oral, Capsule, Delayed Release, Kit, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Oral; Topical, Capsule - Oral; Topical, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Gel - Oral, Suspension - Oral
Rosacea
10.0 mg/mL, , 75.0 mg, 100.0 mg, 150.0 mg, 50.0 mg, 200.0 mg, 20.0 mg, 1.0 mg/mg, 40.0 mg, 5.0 mg/mg, 7.5 mg/mg, 25.0 mg/mL, 50.0 mg/mL, 120.0 mg, 60.0 mg, 0.1 mg/mg, 5.0 mg/mL, 8.8 %, 20.0 mg/mL, 0.75 mg/mg, 0.5 mg/mg, 80.0 mg
, Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Oral, Tablet, delayed release, Tablet, delayed release - Oral, Capsule, Capsule - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Tablet, coated, Tablet, coated - Oral, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Capsule, extended release - Oral, Capsule, extended release, Powder - Intravenous, Powder, Powder, for suspension, Syrup, Syrup - Oral, Powder, for suspension - Oral, Kit - Oral, For suspension, For suspension - Oral, Capsule, Delayed Release - Oral, Capsule, Delayed Release, Kit, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Oral; Topical, Capsule - Oral; Topical, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Gel - Oral, Suspension - Oral
Listeriosis
10.0 mg/mL, , 75.0 mg, 100.0 mg, 150.0 mg, 50.0 mg, 200.0 mg, 20.0 mg, 1.0 mg/mg, 40.0 mg, 5.0 mg/mg, 7.5 mg/mg, 25.0 mg/mL, 50.0 mg/mL, 120.0 mg, 60.0 mg, 0.1 mg/mg, 5.0 mg/mL, 8.8 %, 20.0 mg/mL, 0.75 mg/mg, 0.5 mg/mg, 80.0 mg
, Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Oral, Tablet, delayed release, Tablet, delayed release - Oral, Capsule, Capsule - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Tablet, coated, Tablet, coated - Oral, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Capsule, extended release - Oral, Capsule, extended release, Powder - Intravenous, Powder, Powder, for suspension, Syrup, Syrup - Oral, Powder, for suspension - Oral, Kit - Oral, For suspension, For suspension - Oral, Capsule, Delayed Release - Oral, Capsule, Delayed Release, Kit, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Oral; Topical, Capsule - Oral; Topical, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Gel - Oral, Suspension - Oral
Necrotizing ulcerative gingivostomatitis
10.0 mg/mL, , 75.0 mg, 100.0 mg, 150.0 mg, 50.0 mg, 200.0 mg, 20.0 mg, 1.0 mg/mg, 40.0 mg, 5.0 mg/mg, 7.5 mg/mg, 25.0 mg/mL, 50.0 mg/mL, 120.0 mg, 60.0 mg, 0.1 mg/mg, 5.0 mg/mL, 8.8 %, 20.0 mg/mL, 0.75 mg/mg, 0.5 mg/mg, 80.0 mg
, Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Oral, Tablet, delayed release, Tablet, delayed release - Oral, Capsule, Capsule - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Tablet, coated, Tablet, coated - Oral, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Capsule, extended release - Oral, Capsule, extended release, Powder - Intravenous, Powder, Powder, for suspension, Syrup, Syrup - Oral, Powder, for suspension - Oral, Kit - Oral, For suspension, For suspension - Oral, Capsule, Delayed Release - Oral, Capsule, Delayed Release, Kit, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Oral; Topical, Capsule - Oral; Topical, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Gel - Oral, Suspension - Oral
Dysentery, Bacillary
10.0 mg/mL, , 75.0 mg, 100.0 mg, 150.0 mg, 50.0 mg, 200.0 mg, 20.0 mg, 1.0 mg/mg, 40.0 mg, 5.0 mg/mg, 7.5 mg/mg, 25.0 mg/mL, 50.0 mg/mL, 120.0 mg, 60.0 mg, 0.1 mg/mg, 5.0 mg/mL, 8.8 %, 20.0 mg/mL, 0.75 mg/mg, 0.5 mg/mg, 80.0 mg
, Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Oral, Tablet, delayed release, Tablet, delayed release - Oral, Capsule, Capsule - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Tablet, coated, Tablet, coated - Oral, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Capsule, extended release - Oral, Capsule, extended release, Powder - Intravenous, Powder, Powder, for suspension, Syrup, Syrup - Oral, Powder, for suspension - Oral, Kit - Oral, For suspension, For suspension - Oral, Capsule, Delayed Release - Oral, Capsule, Delayed Release, Kit, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Oral; Topical, Capsule - Oral; Topical, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Gel - Oral, Suspension - Oral
Pneumococcal Infections
10.0 mg/mL, , 75.0 mg, 100.0 mg, 150.0 mg, 50.0 mg, 200.0 mg, 20.0 mg, 1.0 mg/mg, 40.0 mg, 5.0 mg/mg, 7.5 mg/mg, 25.0 mg/mL, 50.0 mg/mL, 120.0 mg, 60.0 mg, 0.1 mg/mg, 5.0 mg/mL, 8.8 %, 20.0 mg/mL, 0.75 mg/mg, 0.5 mg/mg, 80.0 mg
, Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Oral, Tablet, delayed release, Tablet, delayed release - Oral, Capsule, Capsule - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Tablet, coated, Tablet, coated - Oral, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Capsule, extended release - Oral, Capsule, extended release, Powder - Intravenous, Powder, Powder, for suspension, Syrup, Syrup - Oral, Powder, for suspension - Oral, Kit - Oral, For suspension, For suspension - Oral, Capsule, Delayed Release - Oral, Capsule, Delayed Release, Kit, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Oral; Topical, Capsule - Oral; Topical, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Gel - Oral, Suspension - Oral
Klebsiella Infections
10.0 mg/mL, , 75.0 mg, 100.0 mg, 150.0 mg, 50.0 mg, 200.0 mg, 20.0 mg, 1.0 mg/mg, 40.0 mg, 5.0 mg/mg, 7.5 mg/mg, 25.0 mg/mL, 50.0 mg/mL, 120.0 mg, 60.0 mg, 0.1 mg/mg, 5.0 mg/mL, 8.8 %, 20.0 mg/mL, 0.75 mg/mg, 0.5 mg/mg, 80.0 mg
, Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Oral, Tablet, delayed release, Tablet, delayed release - Oral, Capsule, Capsule - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Tablet, coated, Tablet, coated - Oral, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Capsule, extended release - Oral, Capsule, extended release, Powder - Intravenous, Powder, Powder, for suspension, Syrup, Syrup - Oral, Powder, for suspension - Oral, Kit - Oral, For suspension, For suspension - Oral, Capsule, Delayed Release - Oral, Capsule, Delayed Release, Kit, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Oral; Topical, Capsule - Oral; Topical, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Gel - Oral, Suspension - Oral
Warnings
Vibramycin Contraindications
Condition
Risk Level
Notes
Pulse Frequency
Do Not Combine
Severe Hypersensitivity Reactions
Do Not Combine
Doxycycline may interact with Pulse Frequency
Severe Hypersensitivity Reactions
Do Not Combine
Doxycycline may interact with Pulse Frequency
There are 20 known major drug interactions with Vibramycin.
Common Vibramycin Drug Interactions
Drug Name
Risk Level
Description
Abemaciclib
Major
The metabolism of Abemaciclib can be decreased when combined with Doxycycline.
Acalabrutinib
Major
The metabolism of Acalabrutinib can be decreased when combined with Doxycycline.
Alectinib
Major
The metabolism of Alectinib can be decreased when combined with Doxycycline.
Alpelisib
Major
The metabolism of Alpelisib can be decreased when combined with Doxycycline.
Amdinocillin
Major
The therapeutic efficacy of Amdinocillin can be decreased when used in combination with Doxycycline.
Vibramycin Toxicity & Overdose Risk
The dose of doxycycline that is toxic to rats, mice, and dogs is 2000 mg/kg, 1870 mg/kg, and 500 mg/kg respectively. If someone overdoses on doxycycline, they should stop taking it and receive supportive care. Dialysis will not reduce the amount of doxycycline in the bloodstream.
Vibramycin Novel Uses: Which Conditions Have a Clinical Trial Featuring Vibramycin?
34 active clinical trials are currently underway to determine the effectiveness of Vibramycin in treating Haemophilus Influenzae Infections, Respiratory Tract Infections and Amebic Colitis.
Condition
Clinical Trials
Trial Phases
Plague
0 Actively Recruiting
Plague
0 Actively Recruiting
Epididymo-orchitis gonococcal
0 Actively Recruiting
Lymphogranuloma Venereum
0 Actively Recruiting
Gonorrhea
0 Actively Recruiting
Urinary Tract Infections
9 Actively Recruiting
Not Applicable, Phase 4, Early Phase 1
Chlamydia trachomatis
0 Actively Recruiting
Pneumococcal Infections
0 Actively Recruiting
Urethritis
0 Actively Recruiting
Typhus, Endemic Flea-Borne
0 Actively Recruiting
Clostridium difficile Infection
0 Actively Recruiting
Communicable Diseases
0 Actively Recruiting
Chlamydia Infections
0 Actively Recruiting
inhaled anthrax caused by Bacillus anthracis
0 Actively Recruiting
Calymmatobacterium granulomatis
0 Actively Recruiting
Haemophilus Influenzae Infections
0 Actively Recruiting
Chancroid
0 Actively Recruiting
Klebsiella Infections
0 Actively Recruiting
Rosacea
2 Actively Recruiting
Early Phase 1, Phase 2
Rocky Mountain Spotted Fever
0 Actively Recruiting
Vibramycin Reviews: What are patients saying about Vibramycin?
5
Patient Review
5/5/2019
Vibramycin for Acne
5
Patient Review
5/5/2019
Vibramycin for Acne
3.7
Patient Review
2/9/2021
Vibramycin for A Sexually Transmitted Disease due to Chlamydia
3.7
Patient Review
2/9/2021
Vibramycin for A Sexually Transmitted Disease due to Chlamydia
3
Patient Review
6/27/2022
Vibramycin for infection caused by bacteria
3
Patient Review
4/11/2018
Vibramycin for Pneumonia caused by Bacteria
3
Patient Review
4/11/2018
Vibramycin for Pneumonia caused by Bacteria
3
Patient Review
6/27/2022
Vibramycin for infection caused by bacteria
2.7
Patient Review
5/26/2022
Vibramycin for Acne
2.7
Patient Review
8/14/2022
Vibramycin for infection caused by bacteria
2.7
Patient Review
5/26/2022
Vibramycin for Acne
2.7
Patient Review
8/14/2022
Vibramycin for infection caused by bacteria
2.3
Patient Review
4/14/2022
Vibramycin for Bacterial Urinary Tract Infection
2.3
Patient Review
10/27/2022
Vibramycin for Acne
2.3
Patient Review
10/27/2022
Vibramycin for Acne
2.3
Patient Review
4/14/2022
Vibramycin for Bacterial Urinary Tract Infection
2
Patient Review
4/25/2018
Vibramycin for Acne
2
Patient Review
1/27/2022
Vibramycin for infection caused by bacteria
2
Patient Review
11/1/2022
Vibramycin for Acne Rosacea
2
Patient Review
11/1/2022
Vibramycin for Acne Rosacea
2
Patient Review
4/25/2018
Vibramycin for Acne
2
Patient Review
1/27/2022
Vibramycin for infection caused by bacteria
1
Patient Review
6/19/2022
Vibramycin for Non-Contagious Disease due to Actinomyces Bacteria
1
Patient Review
6/19/2022
Vibramycin for Non-Contagious Disease due to Actinomyces Bacteria
Patient Q&A Section about vibramycin
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
What bacteria does vibramycin treat?
"The text describes various infections caused by different bacteria. Vibrio cholerae causes an infection that can lead to severe diarrhea. Campylobacter fetus causes an infection that can lead to inflammation of the reproductive organs. Plague is a serious infectious disease that is caused by the bacteria Yersinia pestis. A deer fly, flea or tick bite can cause a bacterial infection that can lead to skin infection or pneumonia. Anthrax is a bacteria that can cause stomach or intestine infections."
Answered by AI
Is vibramycin a penicillin?
"Doxycycline (Vibramycin) is a good bacteria fighting alternative for people who are allergic to penicillin. It comes in a generic form and as a liquid for those who have trouble swallowing pills. Doxycycline is safe for most people, but should be used with caution in people age 65 or older and those with kidney problems."
Answered by AI
Is vibramycin a strong antibiotic?
"Vibramycin is one of the most widely prescribed antibiotics in the world, and its safety and efficacy have been well-documented.
Vibramycin is a brand name antibiotic that contains the active ingredient doxycycline. Doxycycline is a powerful antibiotic that is used to treat cholera, typhus, plague, pneumonia, urinary tract infections, eye infections, gut infections, and a host of others. Vibramycin is one of the most widely prescribed antibiotics in the world and its safety and efficacy have been well-documented."
Answered by AI